Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03307122 · ClinicalTrials.gov registry record · NA
Gastrointestinal Tolerance Evaluation of an Infant Formula
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT03307122 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 79 participants.
The verdict
NCT03307122, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
Prospective, double-blind, randomized study of 2 infant formulas.
Interventions
- OTHER Routine Infant Formula 1
- OTHER Routine Infant Formula 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2017-09-21 |
| Est. Completion | 2018-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03307122
The ClinicalTrials.gov registry entry for NCT03307122 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Routine Infant Formula 1 is the first listed.
NCT03307122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03307122 about?
NCT03307122 is a clinical study titled "Gastrointestinal Tolerance Evaluation of an Infant Formula". Prospective, double-blind, randomized study of 2 infant formulas.
What is the current status of trial NCT03307122?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2017-09-21. Estimated completion is 2018-01-19.
What interventions are being tested in trial NCT03307122?
The interventions under investigation include: Routine Infant Formula 1 (OTHER), Routine Infant Formula 2 (OTHER).
Who is sponsoring clinical trial NCT03307122?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.